Clinical Trial Update: A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

A multicenter, prospective phase 3 randomized study evaluating decitabine added to R-CHOP as initial therapy for EBV-positive diffuse large B-cell lymphoma; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Ebv-positive Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Decitabine (Decitabine)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Lymphoma, Large-Cell, Diffuse | Phase 3 | Status: ENROLLING_BY_INVITATION